{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T10:03:56Z","timestamp":1776593036397,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die neue ESC-Leitlinie zum Management von Patienten mit Vorhofflimmern von 2024 f\u00fchrt den <jats:italic>AF-CARE-<\/jats:italic>Pfad als zentrales Akronym des Vorhofflimmermanagements ein. In diesem Zuge r\u00fcckt das Management von Komorbidit\u00e4ten (<jats:italic>Comorbidities<\/jats:italic>) und Risikofaktoren an die erste Stelle des Vorhofflimmermanagements. Aber auch bei der Schlaganfall- und Thromboembolie-Prophylaxe (<jats:italic>Avoidance<\/jats:italic>) zeigt die neue Leitlinie wichtige \u00c4nderungen, wie einen ver\u00e4nderten Risikoscore (CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VA) sowie eine Stellungnahme zur Antikoagulation bei subklinischem Vorhofflimmern. Ebenfalls finden sich \u00c4nderungen in den Konzepten der Rhythmus- und Frequenzkontrolle mit einer Aufwertung der Rhythmuskontrolle und der Katheterablation. Schlussendlich empfiehlt die Leitlinie eine regelm\u00e4\u00dfige Reevaluation des Patientenverlaufs zum optimalen Vorhofflimmermanagement. Diese \u00dcbersicht fasst die wesentlichen Neuerungen zusammen und diskutiert einige Empfehlungen zu Aspekten, die auch anders bewertet werden k\u00f6nnen.<\/jats:p>","DOI":"10.1007\/s00399-024-01053-7","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T23:14:54Z","timestamp":1731539694000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Die 2024 ESC-Leitlinien zum Management von Vorhofflimmern","The 2024 ESC guidelines for management of atrial fibrillation"],"prefix":"10.1007","volume":"35","author":[{"given":"Julian","family":"Wolfes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"5","key":"1053_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, Arbelo\u00a0E, Bax\u00a0JJ, Blomstrom-Lundqvist\u00a0C et\u00a0al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS). Eur Heart\u00a0J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"9","key":"1053_CR2","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s00392-022-02012-3","volume":"111","author":"FK Wegner","year":"2022","unstructured":"Wegner\u00a0FK, Plagwitz\u00a0L, Doldi\u00a0F, Ellermann\u00a0C, Willy\u00a0K, Wolfes\u00a0J et\u00a0al (2022) Machine learning in the detection and management of atrial fibrillation. Clin Res Cardiol 111(9):1010\u20131017","journal-title":"Clin Res Cardiol"},{"issue":"10310","key":"1053_CR3","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","volume":"398","author":"E Svennberg","year":"2021","unstructured":"Svennberg\u00a0E, Friberg\u00a0L, Frykman\u00a0V, Al-Khalili\u00a0F, Engdahl\u00a0J, Rosenqvist\u00a0M (2021) Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a\u00a0multicentre, parallel group, unmasked, randomised controlled trial. Lancet 398(10310):1498\u20131506","journal-title":"Lancet"},{"key":"1053_CR4","doi-asserted-by":"crossref","unstructured":"Lopes RD, Atlas SJ, Go AS, Lubitz SA, McManus DD, Dolor RJ et\u00a0al (2024) Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention. J\u00a0Am Coll Cardiol","DOI":"10.1016\/j.jacc.2024.08.019"},{"key":"1053_CR5","doi-asserted-by":"crossref","unstructured":"Kemp Gudmundsdottir K, Svennberg E, Friberg L, Hygrell T, Frykman V, Al-Khalili F et\u00a0al (2024) Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year Olds to Detect Atrial Fibrillation\u2014STROKESTOP II. Circulation","DOI":"10.1161\/CIRCULATIONAHA.124.071176"},{"issue":"23","key":"1053_CR6","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1001\/jama.2022.8831","volume":"327","author":"NF Marrouche","year":"2022","unstructured":"Marrouche\u00a0NF, Wazni\u00a0O, McGann\u00a0C, Greene\u00a0T, Dean\u00a0JM, Dagher\u00a0L et\u00a0al (2022) Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial. JAMA 327(23):2296\u20132305","journal-title":"JAMA"},{"key":"1053_CR7","doi-asserted-by":"crossref","unstructured":"Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera JA, Chugh SS et\u00a0al (2024) Atrial cardiomyopathy revisited-evolution of a\u00a0concept: a\u00a0clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace 26(9)","DOI":"10.1093\/europace\/euae204"},{"issue":"17","key":"1053_CR8","doi-asserted-by":"publisher","first-page":"e022222","DOI":"10.1161\/JAHA.121.022222","volume":"10","author":"AK Pandey","year":"2021","unstructured":"Pandey\u00a0AK, Okaj\u00a0I, Kaur\u00a0H, Belley-Cote\u00a0EP, Wang\u00a0J, Oraii\u00a0A et\u00a0al (2021) Sodium-Glucose Co-Transporter Inhibitors and Atrial Fibrillation: A\u00a0Systematic Review and Meta-Analysis of Randomized Controlled Trials. J\u00a0Am Heart Assoc 10(17):e22222","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"1053_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","volume":"65","author":"RK Pathak","year":"2015","unstructured":"Pathak\u00a0RK, Middeldorp\u00a0ME, Meredith\u00a0M, Mehta\u00a0AB, Mahajan\u00a0R, Wong\u00a0CX et\u00a0al (2015) Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A\u00a0Long-Term Follow-Up Study (LEGACY). J\u00a0Am Coll Cardiol 65(20):2159\u20132169","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1053_CR10","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/europace\/euz183","volume":"21","author":"E Donnellan","year":"2019","unstructured":"Donnellan\u00a0E, Wazni\u00a0OM, Kanj\u00a0M, Baranowski\u00a0B, Cremer\u00a0P, Harb\u00a0S et\u00a0al (2019) Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. Europace 21(10):1476\u20131483","journal-title":"Europace"},{"issue":"11","key":"1053_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cjca.2019.07.627","volume":"35","author":"K Kadhim","year":"2019","unstructured":"Kadhim\u00a0K, Middeldorp\u00a0ME, Elliott\u00a0AD, Jones\u00a0D, Hendriks\u00a0JML, Gallagher\u00a0C et\u00a0al (2019) Self-Reported Daytime Sleepiness and Sleep-Disordered Breathing in Patients With Atrial Fibrillation: SNOozE-AF. Can J Cardiol 35(11):1457\u20131464","journal-title":"Can J Cardiol"},{"issue":"1","key":"1053_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1817591","volume":"382","author":"A Voskoboinik","year":"2020","unstructured":"Voskoboinik\u00a0A, Kalman\u00a0JM, De Silva\u00a0A, Nicholls\u00a0T, Costello\u00a0B, Nanayakkara\u00a0S et\u00a0al (2020) Alcohol Abstinence in Drinkers with Atrial Fibrillation. N\u00a0Engl J Med 382(1):20\u201328","journal-title":"N Engl J Med"},{"key":"1053_CR13","doi-asserted-by":"crossref","unstructured":"Champsi A, Mobley AR, Subramanian A, Nirantharakumar K, Wang X, Shukla D et\u00a0al (2024) Gender and contemporary risk of adverse events in atrial fibrillation. Eur Heart\u00a0J","DOI":"10.1093\/eurheartj\/ehae539"},{"key":"1053_CR14","doi-asserted-by":"crossref","unstructured":"Wegner FK, Eckardt L (2024) Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation. Trends Cardiovasc Med","DOI":"10.1016\/j.tcm.2024.04.001"},{"issue":"13","key":"1053_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","volume":"389","author":"P Kirchhof","year":"2023","unstructured":"Kirchhof\u00a0P, Toennis\u00a0T, Goette\u00a0A, Camm\u00a0AJ, Diener\u00a0HC, Becher\u00a0N et\u00a0al (2023) Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. N\u00a0Engl J Med 389(13):1167\u20131179","journal-title":"N Engl J Med"},{"issue":"2","key":"1053_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","volume":"390","author":"JS Healey","year":"2024","unstructured":"Healey\u00a0JS, Lopes\u00a0RD, Granger\u00a0CB, Alings\u00a0M, Rivard\u00a0L, McIntyre\u00a0WF et\u00a0al (2024) Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N\u00a0Engl J Med 390(2):107\u2013117","journal-title":"N Engl J Med"},{"issue":"5","key":"1053_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.25700","volume":"87","author":"DJ Seiffge","year":"2020","unstructured":"Seiffge\u00a0DJ, De Marchis\u00a0GM, Koga\u00a0M, Paciaroni\u00a0M, Wilson\u00a0D, Cappellari\u00a0M et\u00a0al (2020) Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation. Ann Neurol 87(5):677\u2013687","journal-title":"Ann Neurol"},{"issue":"22","key":"1053_CR18","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","volume":"384","author":"RP Whitlock","year":"2021","unstructured":"Whitlock\u00a0RP, Belley-Cote\u00a0EP, Paparella\u00a0D, Healey\u00a0JS, Brady\u00a0K, Sharma\u00a0M et\u00a0al (2021) Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. N\u00a0Engl J Med 384(22):2081\u20132091","journal-title":"N Engl J Med"},{"issue":"7","key":"1053_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jacc.2012.11.038","volume":"61","author":"HF Groenveld","year":"2013","unstructured":"Groenveld\u00a0HF, Tijssen\u00a0JG, Crijns\u00a0HJ, Van den Berg\u00a0MP, Hillege\u00a0HL, Alings\u00a0M et\u00a0al (2013) Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a\u00a0background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation). J\u00a0Am Coll Cardiol 61(7):741\u2013748","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"1053_CR20","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1001\/jama.2020.23138","volume":"324","author":"D Kotecha","year":"2020","unstructured":"Kotecha\u00a0D, Bunting\u00a0KV, Gill\u00a0SK, Mehta\u00a0S, Stanbury\u00a0M, Jones\u00a0JC et\u00a0al (2020) Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. JAMA 324(24):2497\u20132508","journal-title":"JAMA"},{"issue":"46","key":"1053_CR21","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","volume":"42","author":"M Brignole","year":"2021","unstructured":"Brignole\u00a0M, Pentimalli\u00a0F, Palmisano\u00a0P, Landolina\u00a0M, Quartieri\u00a0F, Occhetta\u00a0E et\u00a0al (2021) AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart\u00a0J 42(46):4731\u20134739","journal-title":"Eur Heart J"},{"key":"1053_CR22","doi-asserted-by":"crossref","unstructured":"Boehmer AA, Kaess BM, Ruckes C, Meyer C, Metzner A, Rillig A et\u00a0al (2024) Pulmonary Vein Isolation or Pace and Ablate in Elderly Patients With Persistent Atrial Fibrillation (ABLATE Versus PACE)-Rationale, Methods, and Design. Can J Cardiol","DOI":"10.1016\/j.cjca.2024.07.021"},{"issue":"4","key":"1053_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00392-018-1368-2","volume":"108","author":"K Wasmer","year":"2019","unstructured":"Wasmer\u00a0K, Hochadel\u00a0M, Wieneke\u00a0H, Spitzer\u00a0SG, Brachmann\u00a0J, Straube\u00a0F et\u00a0al (2019) Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry. Clin Res Cardiol 108(4):395\u2013401","journal-title":"Clin Res Cardiol"},{"issue":"16","key":"1053_CR24","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1900353","volume":"380","author":"N Pluymaekers","year":"2019","unstructured":"Pluymaekers\u00a0N, Dudink\u00a0E, Luermans\u00a0J, Meeder\u00a0JG, Lenderink\u00a0T, Widdershoven\u00a0J et\u00a0al (2019) Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation. N\u00a0Engl J Med 380(16):1499\u20131508","journal-title":"N Engl J Med"},{"issue":"14","key":"1053_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof\u00a0P, Camm\u00a0AJ, Goette\u00a0A, Brandes\u00a0A, Eckardt\u00a0L, Elvan\u00a0A et\u00a0al (2020) Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N\u00a0Engl J Med 383(14):1305\u20131316","journal-title":"N Engl J Med"},{"issue":"40","key":"1053_CR26","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/eurheartj\/ehac471","volume":"43","author":"L Eckardt","year":"2022","unstructured":"Eckardt\u00a0L, Sehner\u00a0S, Suling\u00a0A, Borof\u00a0K, Breithardt\u00a0G, Crijns\u00a0H et\u00a0al (2022) Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4\u00a0trial. Eur Heart\u00a0J 43(40):4127\u20134144","journal-title":"Eur Heart J"},{"issue":"2","key":"1053_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2212540","volume":"388","author":"JG Andrade","year":"2023","unstructured":"Andrade\u00a0JG, Deyell\u00a0MW, Macle\u00a0L, Wells\u00a0GA, Bennett\u00a0M, Essebag\u00a0V et\u00a0al (2023) Progression of Atrial Fibrillation after Cryoablation or Drug Therapy. N\u00a0Engl J Med 388(2):105\u2013116","journal-title":"N Engl J Med"},{"issue":"1","key":"1053_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar\u00a0JA, Chung\u00a0MK, Armbruster\u00a0AL, Benjamin\u00a0EJ, Chyou\u00a0JY, Cronin\u00a0EM et\u00a0al (2024) 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A\u00a0Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 149(1):e1\u2013e156","journal-title":"Circulation"},{"issue":"11","key":"1053_CR29","doi-asserted-by":"publisher","first-page":"EVIDoa2200141","DOI":"10.1056\/EVIDoa2200141","volume":"1","author":"Y Huo","year":"2022","unstructured":"Huo\u00a0Y, Gaspar\u00a0T, Schonbauer\u00a0R, Wojcik\u00a0M, Fiedler\u00a0L, Roithinger\u00a0FX et\u00a0al (2022) Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation. NEJM Evid 1(11):EVIDoa2200141","journal-title":"NEJM Evid"},{"issue":"3","key":"1053_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/europace\/euaa298","volume":"23","author":"KH Kuck","year":"2021","unstructured":"Kuck\u00a0KH, Lebedev\u00a0DS, Mikhaylov\u00a0EN, Romanov\u00a0A, Geller\u00a0L, Kalejs\u00a0O et\u00a0al (2021) Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace 23(3):362\u2013369","journal-title":"Europace"},{"issue":"5","key":"1053_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.tcm.2023.04.001","volume":"34","author":"L Eckardt","year":"2024","unstructured":"Eckardt\u00a0L, Wolfes\u00a0J, Frommeyer\u00a0G (2024) Benefits of early rhythm control of atrial fibrillation. Trends Cardiovasc Med 34(5):288\u2013294","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"1053_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF, Brachmann\u00a0J, Andresen\u00a0D, Siebels\u00a0J, Boersma\u00a0L, Jordaens\u00a0L et\u00a0al (2018) Catheter ablation for atrial fibrillation with heart failure. N\u00a0Engl J Med 378(5):417\u2013427","journal-title":"N Engl J Med"},{"issue":"15","key":"1053_CR33","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","volume":"389","author":"C Sohns","year":"2023","unstructured":"Sohns\u00a0C, Fox\u00a0H, Marrouche\u00a0NF, Crijns\u00a0H, Costard-Jaeckle\u00a0A, Bergau\u00a0L et\u00a0al (2023) Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. N\u00a0Engl J Med 389(15):1380\u20131389","journal-title":"N Engl J Med"},{"issue":"9","key":"1053_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jacc.2024.06.020","volume":"84","author":"N Mewton","year":"2024","unstructured":"Mewton\u00a0N, Zores\u00a0F, Packer\u00a0M (2024) Catheter Ablation for Atrial Fibrillation in Advanced Heart Failure: Can We Trust the CASTLE-HTx Trial? J\u00a0Am Coll Cardiol 84(9):862\u2013864","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1053_CR35","doi-asserted-by":"publisher","first-page":"e009288","DOI":"10.1161\/CIRCEP.120.009288","volume":"13","author":"DB DeLurgio","year":"2020","unstructured":"DeLurgio\u00a0DB, Crossen\u00a0KJ, Gill\u00a0J, Blauth\u00a0C, Oza\u00a0SR, Magnano\u00a0AR et\u00a0al (2020) Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial. Circ Arrhythm Electrophysiol 13(12):e9288","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1053_CR36","doi-asserted-by":"crossref","unstructured":"Gunawardene MA, Frommeyer G, Ellermann C, Jularic M, Leitz P, Hartmann J et\u00a0al (2023) Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation. J\u00a0Clin Med 12(19)","DOI":"10.3390\/jcm12196304"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-024-01053-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:08:11Z","timestamp":1732792091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-024-01053-7"}},"subtitle":["AF-CARE als neues Credo","AF-CARE as new credo"],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s00399-024-01053-7","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Eckardt: Vortragshonorare und\/oder Reisekostenunterst\u00fctzung von Abbott, Bayer Healthcare, Medtronic, Boston Scientific, Boehringer Ingelheim, Biotronik, BMS, and Daiichi Sankyo. J.\u00a0Wolfes: Vortragshonorare und\/oder Reisekostenunterst\u00fctzung Abbott, Bayer Healthcare, Medtronic, Boston Scientific, Biotronik, Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}